ARCHIVES

In Phase II Study, Vaccine IMA910 Stimulated Immune Response

This article is from The Cancer Letter archive.

Vol. 35 No. 2 | February 24, 2012

Download PDF Visit The Full Archive

Related Articles

NCI Starts “Exceptional Responders” Study

September 26, 2014

In Brief: Mansfield To Head NCI Radiation Research; Cowan Is Acting Chief, Medicine Branch

June 23, 1995

Univ. of Chicago Hospital Apologizes For Overdose Death

June 23, 1995

Cancer Patient Lobby Outlines Agenda For FDA Reform, Seeks Role In Discussion

June 23, 1995

Screening Guidelines Differ Among Major Medical Organizations

January 16, 1998

DCT Advisors Approve Recompetition Of Drug Discovery Groups

June 23, 1995